Ramos-Casals, Manuel.
Manuel Ramos-casals researcher
VIAF ID: 250567604 (Personal)
Permalink: http://viaf.org/viaf/250567604
Preferred Forms
- 100 0 _ ‡a Manuel Ramos-casals ‡c researcher
-
- 100 1 0 ‡a Ramos Casals, Manuel
- 100 1 _ ‡a Ramos-Casals, Manuel
-
- 100 1 _ ‡a Ramos-Casals, Manuel
-
- 100 1 _ ‡a Ramos-Casals, Manuel
- 100 1 _ ‡a Ramos-Casals, Manuel
-
4xx's: Alternate Name Forms (11)
5xx's: Related Names (5)
- 551 _ _ ‡a Barcelona ‡4 ortw ‡4 https://d-nb.info/standards/elementset/gnd#placeOfActivity
- 510 2 _ ‡a Sociedad Española de Medicina de Familia y Comunitaria
- 510 2 _ ‡a Universidad de Barcelona
- 510 2 _ ‡a Universidad de Barcelona ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 510 2 _ ‡a Universitat de Barcelona. Departament de Medicina
Works
Title | Sources |
---|---|
Abordaje del dolor crónico no oncológico. | |
Autoimmune diseases : acute and complex situations | |
The digestive involvement in systemic autoimmune diseases | |
Drugs Targeting B-Cells in Autoimmune Diseases | |
Efectos adversos desencadenados por el uso de terapias biológicas. : clasificación, caracterización y manejo clínico | |
Historia natural de la nefropatía lúpica | |
Influencia de los marcadores inmunológicos en la presentación clínica y en la evolución de pacientes con enfermedades autoinmunes sistémicas caracterizadas por la hiperactividad de los linfocitos B | |
Les malalties autoimmunes a l'Hospital Clínic de Barcelona (1986-2011) = Enfermedades autoinmunes, memorias = autoimmune diseases, report | |
[Mixed cryoglobulinemia. Essential?] | |
Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors | |
Outcome measures for primary Sjögren's syndrome: a comprehensive review | |
Previous antimalarial therapy in patients diagnosed with lupus nephritis: influence on outcomes and survival | |
Primary Sjögren syndrome: hematologic patterns of disease expression | |
[Primary Sjögren's syndrome: clinical and immunologic study of 80 patients] | |
Prognostic Factors of Death in 151 Adults With Hemophagocytic Syndrome: Etiopathogenically Driven Analysis | |
Psychiatric and psychosocial disorders in patients with systemic lupus erythematosus: a longitudinal study of active and inactive stages of the disease. | |
Pulmonary disorders induced by monoclonal antibodies in patients with rheumatologic autoimmune diseases | |
Punctal occlusion in Sjögren's syndrome needs clarification | |
Pure sensory neuropathy in primary Sjögren's syndrome. Longterm prospective followup and review of the literature. | |
Recomendaciones sobre el uso de belimumab en el lupus eritematoso sistémico. Guía de Práctica Clínica GEAS-SEMI | |
Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status. | |
Revisión sistemática del uso de adalimumab en enfermedades autoinmunes. Eficacia y seguridad en 54 pacientes | |
Rituximab and lupus: Good in real life, bad in controlled trials. comment on the article by Lu et al | |
Rituximab in systemic lupus erythematosus: A systematic review of off-label use in 188 cases | |
Rituximab therapy in lupus nephritis: current clinical evidence | |
Role of CD5/CD5L interactions in the homeostasis of regulatory lymphocyte subpopulations and the control of autoimmune disorders | |
[Sacroiliitis and Behçet disease] | |
Sarcoidosis: an update on current pharmacotherapy options and future directions | |
Sarcoidosis or Sjögren syndrome? Clues to defining mimicry or coexistence in 59 cases | |
Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study | |
Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 35 cases | |
SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in systemic lupus erythematosus | |
Síndrome de Sjögren | |
Sjögren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases | |
Sjögren syndrome or sjögren disease? The histological and immunological bias caused by the 2002 criteria | |
Sjogren's syndrome : diagnosis and therapeutics | |
Sjögren's syndrome / Manuel Ramos-Casals, John H. Stone, Haralampos M. Moutsopoulos eds. - London, cop. 2012. | |
Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus | |
Splenectomy for refractory Evans' syndrome associated with antiphospholipid antibodies: report of two cases. | |
Successful treatment of severe Raynaud's phenomenon with bosentan in four patients with systemic sclerosis | |
Systemic autoimmune diseases co-existing with chronic hepatitis C virus infection (the HISPAMEC Registry): patterns of clinical and immunological expression in 180 cases | |
Systemic involvement in primary Sjogren's syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry). | |
Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project". | |
Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults | |
Targeted therapy for systemic sclerosis: how close are we? | |
Terapia biológica en pacientes con miopatía inflamatoria idiopática | |
Terapia deplectiva de células B en el lupus eritematoso sistémico : análisis de la eficácia y seguridad en pacientes graves y/o refractarios | |
Th1/Th2 cytokine imbalance in patients with Sjögren syndrome secondary to hepatitis C virus infection | |
Virus de la hepatitis C y autoinmunidad papel etiopatogénico del VHC en las enfermedades autoinmunes sistémicas |